Holen Sie sich die Stockscreener-App
10.03
4.48%
-0.47
Handel nachbörslich:
10.00
-0.03
-0.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.50
Offen:
$10.33
24-Stunden-Volumen:
24,591
Relative Volume:
0.19
Marktkapitalisierung:
$44.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.10M
KGV:
-1.0372
EPS:
-9.67
Netto-Cashflow:
$-36.82M
1W Leistung:
+1.83%
1M Leistung:
+34.45%
6M Leistung:
-1.27%
1J Leistung:
-35.16%
1-Tages-Spanne:
$9.90
$10.35
1-Wochen-Bereich:
$9.50
$10.50
52-Wochen-Spanne:
$5.3495
$20.67
Tempest Therapeutics Inc Stock (TPST) Company Profile
Firmenname
Tempest Therapeutics Inc
Sektor
Branche
Telefon
415-798-8589
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie TPST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.03 | 45.16M | 0 | -43.10M | -36.82M | -9.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-08 | Eingeleitet | Jefferies | Buy |
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
What is Tempest Therapeutics Inc.’s valuation compared to sectorJuly 2025 Highlights & Long-Term Capital Growth Strategies - khodrobank.com
Risk vs reward if holding onto Tempest Therapeutics Inc.Day Trade & Weekly Return Optimization Plans - Newser
How to interpret RSI for Tempest Therapeutics Inc. stockTrade Analysis Summary & Community Verified Swing Trade Signals - Newser
How to read the order book for Tempest Therapeutics Inc.2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Analyzing Tempest Therapeutics Inc. with multi timeframe charts2025 Key Lessons & Free Accurate Trade Setup Notifications - Newser
Will Tempest Therapeutics Inc. outperform the marketJuly 2025 Trends & Low Risk Profit Maximizing Plans - Newser
Tempest Therapeutics Inc. stock chart pattern explainedWeekly Trade Analysis & Consistent Profit Trade Alerts - Newser
Custom strategy builders for tracking Tempest Therapeutics Inc.July 2025 Closing Moves & Weekly Market Pulse Alerts - Newser
Forecasting Tempest Therapeutics Inc. price range with options dataOil Prices & Smart Swing Trading Alerts - Newser
Using AI based signals to follow Tempest Therapeutics Inc.Quarterly Growth Report & Community Verified Trade Signals - Newser
Order flow analysis tools used on Tempest Therapeutics Inc.2025 Performance Recap & Real-Time Buy Signal Alerts - Newser
Backtesting results for Tempest Therapeutics Inc. trading strategies2025 Volume Leaders & Verified Momentum Stock Watchlist - Newser
Market reaction to Tempest Therapeutics Inc.’s recent newsFed Meeting & Safe Entry Zone Tips - Newser
Chart based exit strategy for Tempest Therapeutics Inc.July 2025 Institutional & Verified Trade Idea Suggestions - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockStock Surge & Reliable Price Breakout Signals - Newser
What is Tempest Therapeutics Inc. s P E ratio telling us2025 Volume Leaders & Momentum Based Trading Ideas - khodrobank.com
Leading vs lagging indicators on Tempest Therapeutics Inc. performanceQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about Tempest Therapeutics Inc.Weekly Trade Report & Detailed Earnings Play Strategies - Newser
What are Tempest Therapeutics Inc.’s recent SEC filings showingQuarterly Portfolio Report & Weekly Breakout Watchlists - khodrobank.com
How Tempest Therapeutics Inc. stock performs during market volatility2025 Growth vs Value & Weekly Market Pulse Updates - Newser
How to build a dashboard for Tempest Therapeutics Inc. stockEarnings Recap Summary & Daily Stock Momentum Reports - Newser
Comparing Tempest Therapeutics Inc. in custom built stock radarsProduct Launch & Short-Term Trading Opportunity Alerts - Newser
Best data tools to analyze Tempest Therapeutics Inc. stockMarket Movers & Verified Technical Signals - Newser
Tempest Therapeutics Inc. stock outlook for YEAREarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Is Tempest Therapeutics Inc. stock bottoming out2025 Volatility Report & AI Driven Stock Movement Reports - Newser
Is Tempest Therapeutics Inc. forming a reversal patternJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
When is the best time to exit Tempest Therapeutics Inc.Market Risk Summary & Safe Capital Growth Stock Tips - Newser
Tempest Therapeutics Inc. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - newsyoung.net
Tempest Therapeutics Inc. Nearing Breakout Level After Bounce getLinesFromResByArray error: size == 0 - thegnnews.com
What technical models suggest about Tempest Therapeutics Inc.’s comeback2025 EndofYear Setup & Trade Opportunity Analysis - Newser
Predicting Tempest Therapeutics Inc. trend using moving averagesJuly 2025 Weekly Recap & Community Consensus Stock Picks - Newser
Multi factor analysis applied to Tempest Therapeutics Inc.Earnings Recap Summary & Precise Trade Entry Recommendations - Newser
Is Tempest Therapeutics Inc. trending in predictive chart modelsJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):